Kinfo
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares logo

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares

HKPDNASDAQHealthcare·US · USD
$0.10
-0.01 (-6.45%)
Prices as of October 5, 2026 · live

Price

Key statistics

Valuation
Market cap5.42M USD
Enterprise value3.61M USD
Trailing P/E6.26
Forward P/E0.00
PEG ratio0.00
Price / sales0.40
Price / book0.27
Profitability
Gross margin0.00%
Operating margin-19.32%
Profit margin-8.46%
Return on assets-5.64%
Return on equity-15.59%
Income (TTM)
Revenue13.43M USD
Gross profit1.39M USD
EBITDA-918.37K USD
Net income-1.14M USD
Diluted EPS-$0.07
Rev. growth (YoY)-31.70%
Balance sheet
Total cash221.84K USD
Total debt1.26M USD
Debt / equity13.13
Current ratio3.86
Book value / share$0.41
Cash flow (TTM)
Operating cash flow-751.60K USD
Levered free cash flow-6.51M USD
Shares & price
Shares outstanding23.50M
Float16.33M
Held by institutions0.61%
Beta0.00
50-day MA$0.27
200-day MA$0.53
52-week high$1.72
52-week low$0.10
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-05-290.740.92+24.32%2026-01-131.361.52+11.76%
About Cellyan Biotechnology Co., Ltd Class A Ordinary Shares

Cellyan Biotechnology Co., Ltd is a Hong Kong-based biotechnology and pharmaceutical services company focused on over-the-counter pharmaceutical cross-border commerce. The company provides OTC pharmaceutical procurement and distribution, along with e-commerce supply chain services that support merchants handling cross-border healthcare products. Its operating activities also include customs clearance, drug registration support, warehousing, packaging, and delivery logistics, forming an integrated service platform for the movement of OTC medicines across Hong Kong and Mainland China. Cellyan Biotechnology Co., Ltd serves the pharmaceutical trade, e-commerce, and logistics segments by linking suppliers, distributors, and online merchants through a coordinated supply chain model. Its Class A Ordinary Shares represent the company’s equity in the public market and are associated with a business centered on regulated pharmaceutical distribution and cross-border fulfillment services.

Sector
Healthcare
Industry
Medical Distribution
CEO
Mr. Chenyu Liang
Employees
11
Headquarters
Yau Tong, Hong Kong
Website
www.9zt.hk

Frequently asked questions about Cellyan Biotechnology Co., Ltd Class A Ordinary Shares